Acorai

Non-invasive cardiac and pulmonary pressure sensing for heart failure management.

Acorai was founded in 2019, is headquartered in Helsingborg, Sweden, lists 1–10 employees, and has $4.5M in recorded funding across 2 rounds.

Headquarters
Helsingborg
Employees
1–10
Founded
2019
Business Model
B2B
Website
acorai.com
Total Funding
$4.5M
Last Round
$4.5M SeedJan 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Acorai is a Swedish medical device company developing a non-invasive cardiac and pulmonary pressure sensing device to improve heart failure management. The company's handheld device uses a patented SAVE Sensor System combining multiple sensors with machine learning to non-invasively estimate intracardiac pressures — data that previously required invasive catheterization procedures. By enabling continuous, outpatient monitoring of hemodynamic congestion, Acorai aims to help healthcare professionals personalize heart failure therapy, reduce hospitalizations, and improve patient outcomes. Founded in 2019 and headquartered in Helsingborg, Sweden, Acorai received FDA Breakthrough Device Designation in 2023, which recognizes devices that provide more effective treatment or diagnosis of life-threatening conditions.

Summary

Acorai is a Deep Tech company based in Helsingborg, Sweden, founded in 2019. It lists 1–10 employees. It has raised $4.5M in total across 2 rounds, most recently a $4.5M Seed round in Jan 2024. Investors include Solardis Health Ventures, European Innovation Council Fund and Meridian Health Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2024
$4.5M

Sign up to see all 2 events

Funding: Grant through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Acorai on Indexed.vc
<a href="https://indexed.vc/companies/acorai"><img src="https://indexed.vc/api/badge/company/acorai" alt="Acorai on Indexed.vc" width="260" height="76" /></a>